Rosiglitazone

Rediff.com » News » Rosiglitazone

News for Rosiglitazone

Business

It's a tough road ahead for pharma companies

Post Ranbaxy episode, domestic pharma companies may face frequent inspections and deeper scrutiny. These companies need to ensure that not only their own quality and standards improve but also......

Health Min may ban two drugs soon

The Union Health Ministry may ban two drugs, Gatifloxacin and Tegaserod, soon. Gatifloxacin is an antibiotic and Tegaserod is meant to treat irritable bowel syndrome.The move comes after......

Three controversial drugs may be banned

The Central Drugs Standard Control Organisation (CDSCO), the apex drug regulator, may soon ban the production and sale of three medicines in the country.The drugs - cisapride, phenylpropanolamine......

GSK India clones local strategy

Deviating from the global business strategy of its UK parent, GlaxoSmithKline Pharmaceuticals India, the largest multinational drugs company in the country, is planning to sell in India drugs that......

Diabetes: India faces economic burden

The number of diabetic patients in the country, which was 31.7 million 2000, is expected to shoot up to 79.4 million by the year 2030, according to the World Health Organisation.India is followed......

Rediff News

Rosiglitazone

News for Rosiglitazone

It's a tough road ahead for pharma companies

Health Min may ban two drugs soon

Three controversial drugs may be banned

GSK India clones local strategy

Diabetes: India faces economic burden

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS